Literature DB >> 11892694

A case of adult onset Still's disease treated with infliximab.

P Caramaschi, D Biasi, A Carletto, L M Bambara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11892694

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  8 in total

Review 1.  Diagnosis and management of adult onset Still's disease.

Authors:  P Efthimiou; P K Paik; L Bielory
Journal:  Ann Rheum Dis       Date:  2005-10-11       Impact factor: 19.103

2.  Prolonged remission in adult-onset Still's disease with etanercept.

Authors:  Rakesh Kumari; Sukhbir S Uppal
Journal:  Clin Rheumatol       Date:  2005-04-23       Impact factor: 2.980

3.  Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients.

Authors:  Alexander Kokkinos; Alexios Iliopoulos; Paraskevi Greka; Anna Efthymiou; Nicholas Katsilambros; Petros P Sfikakis
Journal:  Clin Rheumatol       Date:  2003-11-15       Impact factor: 2.980

Review 4.  Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances.

Authors:  Apostolos Kontzias; Petros Efthimiou
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Is anti-TNF switching in refractory Still's disease safe and effective?

Authors:  Nadia Emi Aikawa; Ana Cristina de Medeiros Ribeiro; Carla Gonçalves Schain Saad; Rosa Maria Rodrigues Pereira; Mauricio Levy; Clovis A Silva; Eloísa Bonfá; Jozélio Freire de Carvalho
Journal:  Clin Rheumatol       Date:  2011-04-05       Impact factor: 3.650

6.  Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study.

Authors:  Katerina Laskari; Athanasios G Tzioufas; Haralampos M Moutsopoulos
Journal:  Arthritis Res Ther       Date:  2011-06-17       Impact factor: 5.156

7.  Adult-Onset Still's Disease: A Case Report and Review of Current Therapeutic Options.

Authors:  Steffi Thomas; Vartika Kesarwani; Melanie Graber; Weishali Joshi
Journal:  Cureus       Date:  2022-03-01

8.  Successful treatment of refractory adult Still's disease and membranous glomerulonephritis with infliximab.

Authors:  Taner Babacan; Ahmet Mesut Onat; Yavuz Pehlivan; Gazi Comez; Metin Karakök
Journal:  Clin Rheumatol       Date:  2010-01-26       Impact factor: 3.650
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.